Skip to main content
Article thumbnail
Location of Repository

Successful radiotherapy for local control of progressively increasing metastasis of gastrointestinal stromal tumor

By Cristian Lolli, Maria Abbondanza Pantaleo, Margherita Nannini, Maristella Saponara, Maria Caterina Pallotti, Valerio Di Scioscio, Enza Barbieri, Anna Mandrioli and Guido Biasco


Gastrointestinal stromal tumors (GISTs) are known to be poorly responsive to conventional chemotherapy and historically considered resistant to radiotherapy. In the past the mainstay of GIST treatment was surgery, but the introduction of tyrosine kinase inhibitors (TKIs) imatinib and sunitinib marked the beginning of a new era in the treatment of GIST patients. To date, radiotherapy for GIST has not been administered in clinical practice except for limited palliative settings and there are no clear data on the administration of radiotherapy, alone or in combination with TKIs, with a purely cytoreductive intent. We describe the clinical case of a 48-year-old woman with metastatic GIST treated with external radiotherapy in a critical supraclavicular tumor localization progressively increasing in size with several symptoms and not responsive to systemic TKI therapies. We obtained an initial shrinkage of the mass and subsequent stabilization with an immediate and clear clinical benefit. Although the historical medical literature considered GISTs resistant to radiation therapy, our clinical case suggests this treatment may be appropriate in selected patients

Topics: Case Report
Publisher: PAGEPress Publications
OAI identifier:
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    1. Adjuvant radiotherapy for gastrointestinal stromal tumor of the rectum. Dig Dis Sci 2001;46:268-72. Case Report
    2. Biology of gastrointestinal stromal tumors.
    3. (2002). Clinical management of gastrointestinal stromal tumors: before and after STI-571. Hum Pathol
    4. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.
    5. Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial.
    6. (1998). Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors.
    7. (2010). Gastrointestinal stromal tumor of the rectum with bone and liver metastasis: a case study. Med Oncol
    8. Gastrointestinal stromal tumors: pathology and prognosis at different sites.
    9. (2001). Long-term control for a retroperitoneal metastasis of malignant gastrointestinal stromal tumor after chemoradiotherapy and immunotherapy. Acta Oncol
    10. Molecular targeted therapy of gastrointestinal stromal tumors.
    11. (2009). Molecularly targeted therapy and radiotherapy in the management of localized gastrointestinal stromal tumor (GIST) of the rectum: a case report. Tumori.
    12. Novel approaches to imatiniband sunitinib-resistant GIST.
    13. Three cases of bone metastases in patients with gastrointestinal stromal tumors. Rare Tumors 2011;3:e17.
    14. Update on the biology and therapy of gastrointestinal stromal tumors.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.